GLOBUS MEDICAL INC

Globus Medical, Inc. develops and commercializes healthcare solutions designed to treat musculoskeletal disorders and improve patient quality of life. The company operates through two primary product categories: Musculoskeletal Solutions and Enabling Technologies. Its offerings include spinal implants, motion preservation devices, regenerative biologics, orthopedic trauma hardware, joint replacement systems, and spinal cord stimulation therapies for chronic pain management. Globus also provides intraoperative neuromonitoring services and advanced surgical systems comprising robotic guidance, imaging platforms, navigation headsets, and surgical planning software. The company primarily serves surgeons, physicians, ambulatory surgery centers, and hospitals.

Headquartered in Audubon, Pennsylvania, Globus distributes its technologies across 65 countries worldwide, operating in the United States and 64 international territories. The company maintains in-house implant manufacturing facilities in Eagleville and Limerick, Pennsylvania, as well as West Carrollton, Ohio. Biologics processing is conducted in Audubon, Pennsylvania, and San Antonio, Texas. In addition, Globus manufactures spinal cord stimulation products in Costa Rica and assembles its robotic surgical platforms in Methuen, Massachusetts.

Summary of the business section of Globus Medical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had over 6,000 employees worldwide, including sales and marketing, product development, operations, general administrative and accounting, both domestically and internationally.”